Tamoxifen Citrate Hilma Biocare

Tamoxifen Citrate by Hilma Biocare, best known as Nolvadex, is a potent selective estrogen receptor modulator (SERM) and one of the most trusted post-cycle therapy compounds. Medically it treats and prevents breast cancer; in the athletic world it blocks estrogen at the breast tissue to prevent and even reverse gynecomastia, reduce water retention and — most importantly — restart natural testosterone production after a cycle by stimulating LH and FSH.

Effects and benefits

Tamoxifen occupies estrogen receptors in breast tissue, preventing and treating gynecomastia, while its action on the hypothalamus prompts a rise in LH and FSH that restarts endogenous testosterone. That dual role makes it a cornerstone of almost every SERM-based PCT protocol.

• Prevents and treats gynecomastia
• Reduces water retention
• Restarts natural testosterone production
• Reliable, well-studied PCT compound

Dosage and administration

A typical PCT runs 20–40 mg per day for several weeks, tapering as recovery progresses. As a recovery agent it belongs in a structured post cycle therapy plan rather than in the anabolic phase.

Stacking and combinations

Tamoxifen is frequently paired with Clomiphene Citrate for a stronger recovery, while an aromatase inhibitor like Anastrozole handles estrogen during the active cycle.

Why choose Hilma Biocare

Every batch is produced to consistent pharmaceutical standards with dependable dosing you can trust for recovery. Explore the complete Hilma Biocare catalogue to build a matching PCT plan.